List of Excipients in API ABACAVIR SULFATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ABACAVIR SULFATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| ViiV Healthcare Company | ZIAGEN | abacavir sulfate | 49702-221 | CELLULOSE, MICROCRYSTALLINE | |
| ViiV Healthcare Company | ZIAGEN | abacavir sulfate | 49702-221 | FERRIC OXIDE YELLOW | |
| ViiV Healthcare Company | ZIAGEN | abacavir sulfate | 49702-221 | HYPROMELLOSE | |
| ViiV Healthcare Company | ZIAGEN | abacavir sulfate | 49702-221 | MAGNESIUM STEARATE | |
| ViiV Healthcare Company | ZIAGEN | abacavir sulfate | 49702-221 | POLYSORBATE 80 | |
| ViiV Healthcare Company | ZIAGEN | abacavir sulfate | 49702-221 | SILICON DIOXIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing ABACAVIR SULFATE
Detailed excipient profiles for ABACAVIR SULFATE
Excipient focus: ANHYDROUS CITRIC ACID
ABACAVIR SULFATE drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | abacavir sulfate | 64980-405 |
| Aurobindo Pharma Limited | abacavir sulfate | 65862-089 |
| >Company | >Ingredient | >NDC |
ABACAVIR SULFATE drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: BANANA
ABACAVIR SULFATE drug variants containing BANANA
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | abacavir sulfate | 64980-405 |
| Aurobindo Pharma Limited | abacavir sulfate | 65862-089 |
| >Company | >Ingredient | >NDC |
ABACAVIR SULFATE drug variants not containing BANANA
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ABACAVIR SULFATE drug variants containing CELLULOSE, MICROCRYSTALLINE
ABACAVIR SULFATE drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | abacavir sulfate | 64980-405 |
| Aurobindo Pharma Limited | abacavir sulfate | 65862-089 |
| >Company | >Ingredient | >NDC |
Excipient focus: COLLOIDAL SILICON DIOXIDE
ABACAVIR SULFATE drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | abacavir sulfate | 53808-0811 |
| >Company | >Ingredient | >NDC |
ABACAVIR SULFATE drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSCARMELLOSE SODIUM
ABACAVIR SULFATE drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | abacavir sulfate | 0904-6523 |
| >Company | >Ingredient | >NDC |
ABACAVIR SULFATE drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
ABACAVIR SULFATE drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| LUPIN LIMITED | abacavir sulfate, lamivudine and zidovudine | 57297-286 |
| >Company | >Ingredient | >NDC |
ABACAVIR SULFATE drug variants not containing CROSPOVIDONE
Excipient focus: FD&C BLUE NO. 2
ABACAVIR SULFATE drug variants containing FD&C BLUE NO. 2
ABACAVIR SULFATE drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C YELLOW NO. 6
ABACAVIR SULFATE drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| ViiV Healthcare Company | abacavir sulfate and lamivudine | 49702-206 |
| State of Florida DOH Central Pharmacy | abacavir sulfate and lamivudine | 53808-0767 |
| Physicians Total Care Inc | abacavir sulfate and lamivudine | 54868-5600 |
| >Company | >Ingredient | >NDC |
ABACAVIR SULFATE drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
ABACAVIR SULFATE drug variants containing FERRIC OXIDE RED
ABACAVIR SULFATE drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
ABACAVIR SULFATE drug variants containing FERRIC OXIDE YELLOW
ABACAVIR SULFATE drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
ABACAVIR SULFATE drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| ViiV Healthcare Company | abacavir sulfate, dolutegravir sodium, lamivudine | 49702-231 |
| >Company | >Ingredient | >NDC |
ABACAVIR SULFATE drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYPROMELLOSE
ABACAVIR SULFATE drug variants containing HYPROMELLOSE
ABACAVIR SULFATE drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSES
ABACAVIR SULFATE drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | abacavir sulfate | 53808-0627 |
| State of Florida DOH Central Pharmacy | abacavir sulfate, lamivudine, and zidovudine | 53808-0990 |
| >Company | >Ingredient | >NDC |
ABACAVIR SULFATE drug variants not containing HYPROMELLOSES
Excipient focus: MAGNESIUM STEARATE
ABACAVIR SULFATE drug variants containing MAGNESIUM STEARATE
ABACAVIR SULFATE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | abacavir sulfate | 64980-405 |
| Aurobindo Pharma Limited | abacavir sulfate | 65862-089 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
ABACAVIR SULFATE drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| ViiV Healthcare Company | abacavir sulfate, dolutegravir sodium, lamivudine | 49702-231 |
| >Company | >Ingredient | >NDC |
ABACAVIR SULFATE drug variants not containing MANNITOL
Excipient focus: METHYLPARABEN
ABACAVIR SULFATE drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | abacavir sulfate | 64980-405 |
| Aurobindo Pharma Limited | abacavir sulfate | 65862-089 |
| >Company | >Ingredient | >NDC |
ABACAVIR SULFATE drug variants not containing METHYLPARABEN
Excipient focus: POLYETHYLENE GLYCOL
ABACAVIR SULFATE drug variants containing POLYETHYLENE GLYCOL
ABACAVIR SULFATE drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
ABACAVIR SULFATE drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| ViiV Healthcare Company | abacavir sulfate and lamivudine | 49702-206 |
| State of Florida DOH Central Pharmacy | abacavir sulfate and lamivudine | 53808-0767 |
| Physicians Total Care Inc | abacavir sulfate and lamivudine | 54868-5600 |
| >Company | >Ingredient | >NDC |
ABACAVIR SULFATE drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 8000
ABACAVIR SULFATE drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | abacavir sulfate | 0904-6523 |
| >Company | >Ingredient | >NDC |
ABACAVIR SULFATE drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYETHYLENE GLYCOLS
ABACAVIR SULFATE drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | abacavir sulfate | 53808-0627 |
| LUPIN LIMITED | abacavir sulfate, lamivudine and zidovudine | 57297-286 |
| State of Florida DOH Central Pharmacy | abacavir sulfate, lamivudine, and zidovudine | 53808-0990 |
| >Company | >Ingredient | >NDC |
ABACAVIR SULFATE drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYSORBATE 80
ABACAVIR SULFATE drug variants containing POLYSORBATE 80
ABACAVIR SULFATE drug variants not containing POLYSORBATE 80
Excipient focus: POLYVINYL ALCOHOL
ABACAVIR SULFATE drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| ViiV Healthcare Company | abacavir sulfate, dolutegravir sodium, lamivudine | 49702-231 |
| LUPIN LIMITED | abacavir sulfate, lamivudine and zidovudine | 57297-286 |
| >Company | >Ingredient | >NDC |
ABACAVIR SULFATE drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE
ABACAVIR SULFATE drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| ViiV Healthcare Company | abacavir sulfate, dolutegravir sodium, lamivudine | 49702-231 |
| LUPIN LIMITED | abacavir sulfate, lamivudine and zidovudine | 57297-286 |
| >Company | >Ingredient | >NDC |
ABACAVIR SULFATE drug variants not containing POVIDONE
Excipient focus: PROPYLENE GLYCOL
ABACAVIR SULFATE drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | abacavir sulfate | 64980-405 |
| Aurobindo Pharma Limited | abacavir sulfate | 65862-089 |
| >Company | >Ingredient | >NDC |
ABACAVIR SULFATE drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN
ABACAVIR SULFATE drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | abacavir sulfate | 64980-405 |
| Aurobindo Pharma Limited | abacavir sulfate | 65862-089 |
| >Company | >Ingredient | >NDC |
ABACAVIR SULFATE drug variants not containing PROPYLPARABEN
Excipient focus: SACCHARIN SODIUM
ABACAVIR SULFATE drug variants containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | abacavir sulfate | 64980-405 |
| Aurobindo Pharma Limited | abacavir sulfate | 65862-089 |
| >Company | >Ingredient | >NDC |
ABACAVIR SULFATE drug variants not containing SACCHARIN SODIUM
Excipient focus: SILICON DIOXIDE
ABACAVIR SULFATE drug variants containing SILICON DIOXIDE
ABACAVIR SULFATE drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN
ABACAVIR SULFATE drug variants containing SODIUM STARCH GLYCOLATE TYPE A CORN
| Company | Ingredient | NDC |
|---|---|---|
| ViiV Healthcare Company | abacavir sulfate, dolutegravir sodium, lamivudine | 49702-231 |
| >Company | >Ingredient | >NDC |
ABACAVIR SULFATE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A CORN
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
ABACAVIR SULFATE drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
ABACAVIR SULFATE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SORBITOL
ABACAVIR SULFATE drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | abacavir sulfate | 64980-405 |
| Aurobindo Pharma Limited | abacavir sulfate | 65862-089 |
| >Company | >Ingredient | >NDC |
ABACAVIR SULFATE drug variants not containing SORBITOL
Excipient focus: STRAWBERRY
ABACAVIR SULFATE drug variants containing STRAWBERRY
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | abacavir sulfate | 64980-405 |
| Aurobindo Pharma Limited | abacavir sulfate | 65862-089 |
| >Company | >Ingredient | >NDC |
ABACAVIR SULFATE drug variants not containing STRAWBERRY
Excipient focus: TALC
ABACAVIR SULFATE drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| ViiV Healthcare Company | abacavir sulfate, dolutegravir sodium, lamivudine | 49702-231 |
| LUPIN LIMITED | abacavir sulfate, lamivudine and zidovudine | 57297-286 |
| >Company | >Ingredient | >NDC |
ABACAVIR SULFATE drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
ABACAVIR SULFATE drug variants containing TITANIUM DIOXIDE
ABACAVIR SULFATE drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | abacavir sulfate | 64980-405 |
| Aurobindo Pharma Limited | abacavir sulfate | 65862-089 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
ABACAVIR SULFATE drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| ViiV Healthcare Company | abacavir sulfate | 49702-221 |
| State of Florida DOH Central Pharmacy | abacavir sulfate | 53808-0811 |
| >Company | >Ingredient | >NDC |
ABACAVIR SULFATE drug variants not containing TRIACETIN
Excipient focus: TRISODIUM CITRATE DIHYDRATE
ABACAVIR SULFATE drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | abacavir sulfate | 64980-405 |
| Aurobindo Pharma Limited | abacavir sulfate | 65862-089 |
| >Company | >Ingredient | >NDC |
ABACAVIR SULFATE drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
ABACAVIR SULFATE drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | abacavir sulfate | 64980-405 |
| Aurobindo Pharma Limited | abacavir sulfate | 65862-089 |
| >Company | >Ingredient | >NDC |
ABACAVIR SULFATE drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links